Abstract
Rates of Myasthenic Crisis, Exacerbation and Healthcare Resource Utilization in Eculizumab-treated Patients with Generalized Myasthenia Gravis in a Global Registry (S38.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have